CONNECTs
Our programmes
- See All
- Podcast
- Experts knowledge share
- E-learning
- Video
- Publication
- Other
Endocrinology Pediatrics Oncology
Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
Experts
Dr Luca Toschi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Downloadable 
5 MIN
Sep 2021 
-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 3 – Characterisation of adverse events caused by TRK inhibitor therapy
Experts
Prof. Ezra Cohen-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Current opinions on how to identify and treat NTRK fusion positive cancer
Experts
Prof. David Hong, Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca-
Downloadable
Resouces -
5 MIN
-
Sep 2021
-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Pediatrics Endocrinology
Learn about the patient journey through diagnosis and treatment of NTRK fusion positive cancer
Experts
Prof. Ulrik Lassen, Assoc. Prof. Caterina Marchiò-
5 MIN
-
Sep 2021
Endocrinology Pediatrics Oncology
Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer
Experts
Prof. Fernando López-Ríos-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
Experts
Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Assoc. Prof. Gerald Prager-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 1 – Larotrectinib and Entrectinib efficacy and safety profile in solid tumours
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK CONNECT Update from ESMO 2019
Experts
Assoc. Prof. Caterina Marchiò-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from USCAP, ELCC and AACR 2021
Experts
Dr Fernando Santini-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology
PARP inhibition and DNA Damage Response (DDR)
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Experts
Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley-
30 MIN
-
Oct 2021
Oncology
COR2ED at ESMO 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
-
2 MIN
-
Sep 2022
Oncology
Update From ESMO 2022 Presidential Sessions
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo-
10 MIN
-
Sep 2022
Micro learning
Oncology
Recognising, Diagnosing and Managing Neuroendocrine Tumours
Watch the video, download the slides and summary flashcard, and take the assessment
Experts
Dr Jaume Capdevila, Asst. Prof. Mauro CivesEndorsed by
-
Downloadable
Resouces -
30 MIN
-
Aug 2023
